We are live on ! Find out more
AC

AXQ Capital Portfolio holdings

AUM $777M
1-Year Est. Return 9.87%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
10 Year Est. Return
AUM
$261M
AUM Growth
-$48.6M
Cap. Flow
-$50.8M
Cap. Flow %
-19.47%
Top 10 Hldgs %
6.83%
Holding
876
New
329
Increased
101
Reduced
119
Closed
326

Top Buys

Rank Stock Value
1
DOV icon
Dover
DOV
+$2.13M
2
EOG icon
EOG Resources
EOG
+$1.7M
3
PRU icon
Prudential Financial
PRU
+$1.58M
4
GILD icon
Gilead Sciences
GILD
+$1.56M
5
CE icon
Celanese
CE
+$1.54M

Top Sells

Rank Stock Value
1
CCL icon
Carnival Corporation Ltd
CCL
+$2.43M
2
TMO icon
Thermo Fisher Scientific
TMO
+$2.27M
3
WU icon
Western Union
WU
+$1.82M
4
ABBV icon
AbbVie
ABBV
+$1.8M
5
NVDA icon
NVIDIA
NVDA
+$1.8M

Sector Composition

Rank Sector Weight
1 Technology 19.25%
2 Industrials 17.8%
3 Financials 13.71%
4 Healthcare 12.46%
5 Consumer Discretionary 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRMR icon
501
Larimar Therapeutics
LRMR
$397M
$122K 0.05%
37,771
+17,918
+90% +$67.2K
GOSS icon
502
Gossamer Bio
GOSS
$82.9M
$122K 0.05%
+46,367
New +$102K
SEMR
503
DELISTED
Semrush
SEMR
$119K 0.05%
+16,781
New +$137K
HPK icon
504
HighPeak Energy
HPK
$903M
$117K 0.04%
+16,523
New +$136K
TALO icon
505
Talos Energy
TALO
$2.53B
$116K 0.04%
+12,129
New +$109K
ATXS
506
DELISTED
Astria Therapeutics
ATXS
$115K 0.04%
+15,823
New +$107K
DAWN
507
DELISTED
Day One Biopharmaceuticals
DAWN
$115K 0.04%
+16,306
New +$112K
PDYN icon
508
Palladyne AI
PDYN
$247M
$115K 0.04%
+13,348
New +$111K
LAZR
509
DELISTED
Luminar Technologies
LAZR
$115K 0.04%
+60,013
New +$147K
MASS icon
510
908 Devices
MASS
$329M
$114K 0.04%
+13,045
New +$86.7K
TNGX icon
511
Tango Therapeutics
TNGX
$4.43B
$113K 0.04%
+13,468
New +$91.1K
FDMT icon
512
4D Molecular Therapeutics
FDMT
$532M
$112K 0.04%
+12,879
New +$77K
FLWS icon
513
1-800-Flowers.com
FLWS
$250M
$109K 0.04%
+23,625
New +$130K
OEC icon
514
Orion
OEC
$381M
$109K 0.04%
14,337
+2,474
+21% +$25K
ESPR
515
DELISTED
Esperion Therapeutics
ESPR
$103K 0.04%
+38,930
New +$75.3K
WEST icon
516
Westrock Coffee
WEST
$792M
$102K 0.04%
+20,923
New +$126K
TTGT icon
517
TechTarget
TTGT
$325M
$101K 0.04%
+17,332
New +$115K
LXEO icon
518
Lexeo Therapeutics
LXEO
$324M
$99.1K 0.04%
14,921
+2,446
+20% +$11.8K
LDI icon
519
loanDepot
LDI
$532M
$96.1K 0.04%
+31,308
New +$72.3K
BLZE icon
520
Backblaze
BLZE
$823M
$95.8K 0.04%
+10,322
New +$75.8K
ARQ icon
521
Arq
ARQ
$84.6M
$95.8K 0.04%
+13,374
New +$88.3K
MCW
522
DELISTED
Mister Car Wash
MCW
$90.9K 0.03%
+17,062
New +$101K
ANNX icon
523
Annexon
ANNX
$834M
$85K 0.03%
+27,867
New +$69.2K
BLMN icon
524
Bloomin' Brands
BLMN
$741M
$83.9K 0.03%
11,700
-2,533
-18% -$20.4K
MYGN icon
525
Myriad Genetics
MYGN
$270M
$82.8K 0.03%
+11,448
New +$68K

Similar funds

AXQ Capital's Q3 2025 Portfolio in Review

As of Q3 2025, AXQ Capital held 876 positions worth $261M, down 16% from $310M the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

AXQ Capital withdrew a net $50.8M in Q3 2025, closing 326 positions and reducing 119 holdings. Its most notable exit was Carnival Corporation Ltd, an estimated $2.43M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Financials.

Against the trend, AXQ Capital opened a new position in Dover worth $1.98M.

  • AXQ Capital's largest Q3 2025 buy was Dover: 11,844 shares worth $1.98M.
  • AXQ Capital added most to Arista Networks in Q3 2025, an estimated $1.2M increase.
  • AXQ Capital's biggest Q3 2025 reduction was Western Union, cutting an estimated $1.82M.
  • AXQ Capital fully exited Carnival Corporation Ltd in Q3 2025, selling an estimated $2.43M.
  • AXQ Capital's ten largest holdings make up 6.8% of its $261M portfolio in Q3 2025.
  • AXQ Capital opened 329 new positions and closed 326 in Q3 2025.
  • AXQ Capital's portfolio value fell 16% quarter-over-quarter to $261M.

Based on AXQ Capital's 13F filing for Q3 2025, filed 10 Nov 2025.